Herzliya Medical Center
Tel: +972-9-959-4888
09:00-18:00
Glioma is the most common primary tumor of the brain or spinal cord. The treatment in Israel is planned individually based on the specific type of tumor, its size, and location.
Neurosurgeons, neuro-oncology, radiology, and other specialists at Herzliya Medical Center plan treatment for each individual case.
Astrocytoma is among the highest in the frequency of gliomas. They, in turn, are classified by grade, which is determined by the number of atypical (undifferentiated) cells and necrotic foci. Treatment of glioma in Israel is planned in accordance with the histological tumor type and grade. For example, low-grade astrocytoma which grows slowly may be subjected to surgical removal, and in some cases, doctors recommend confine medical supervision.
Anaplastic astrocytoma and glioblastoma – poorly differentiated tumors – require surgical removal, as well as conservative measures: chemotherapy and / or radiotherapy. These tumors often recur, and their prognosis is rather unfavorable.
Diagnosis of gliomas involves determining the histological tumor type and the degree of malignancy by biopsy.
The diagnosis of glioma is carried out by tumor imaging with an estimation of its size and location, which intends to establish the extent of the presence of neoplasms affecting the functions of the central nervous system, blood circulation, and circulation of cerebrospinal fluid.
Surgical treatment of glioma in Israel is carried out using modern neurosurgical techniques:
The objective of the surgeon during surgery is tumor resection to the maximum extent while maintaining the integrity of critical brain structures.
Modern radiotherapy techniques allow for a significant portion of patients to stop tumor growth and achieve remission, and in some cases, they offer a cure for cancer.
Radiotherapy techniques include :
For the treatment of gliomas, chemoradiotherapy is used; a combination of radiation and chemotherapy.
At Herzliya Medical Center Oncology Department, the treatment of glioma applies the latest techniques, the effectiveness of which has been confirmed by repeated clinical trials. These include biological therapy, encouraging the immune system to attack cancer tumors, and molecular targeted therapy, with a selective effect on malignant cells.